387 related articles for article (PubMed ID: 35821178)
1. Role of Chemokines in the Development and Progression of Alzheimer's Disease.
Wojcieszak J; Kuczyńska K; Zawilska JB
J Mol Neurosci; 2022 Sep; 72(9):1929-1951. PubMed ID: 35821178
[TBL] [Abstract][Full Text] [Related]
2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
3. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.
Liu B; Rasool S; Yang Z; Glabe CG; Schreiber SS; Ge J; Tan Z
Am J Pathol; 2009 Nov; 175(5):2099-110. PubMed ID: 19834067
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
[TBL] [Abstract][Full Text] [Related]
8. Endocytosis and Alzheimer's disease.
Zadka Ł; Sochocka M; Hachiya N; Chojdak-Łukasiewicz J; Dzięgiel P; Piasecki E; Leszek J
Geroscience; 2024 Feb; 46(1):71-85. PubMed ID: 37646904
[TBL] [Abstract][Full Text] [Related]
9. A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer's disease.
Thuraisingham RA
Metab Brain Dis; 2022 Mar; 37(3):801-805. PubMed ID: 35032278
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
12. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
13. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. [Pathological changes induced by amyloid-β in Alzheimer's disease].
Takata K; Kitamura Y; Taniguchi T
Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
[TBL] [Abstract][Full Text] [Related]
16. Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice.
Rueda N; Vidal V; García-Cerro S; Narcís JO; Llorens-Martín M; Corrales A; Lantigua S; Iglesias M; Merino J; Merino R; Martínez-Cué C
Brain Behav Immun; 2018 Oct; 73():235-251. PubMed ID: 29758264
[TBL] [Abstract][Full Text] [Related]
17. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
Althafar ZM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
[TBL] [Abstract][Full Text] [Related]
18. The Role of Chemokines in Alzheimer's Disease.
Jorda A; Campos-Campos J; Iradi A; Aldasoro M; Aldasoro C; Vila JM; Valles SL
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1383-1390. PubMed ID: 32003705
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
20. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
